A meta-analysis data further supported its prognostic significance, showing that high S100A8 expression is associated with worse overall, disease-free, and progression-free survival, particularly in patients with breast and bladder cancers, and was found to be associated with tumor differentiation and lymphatic metastasis [30]. This evidence concerns the gene S100A8 and urinary bladder cancer.